Orig Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.00 Cr
as on 05-12-2024
- Satisfied Charges ₹ 6.57 M
as on 05-12-2024
- Revenue 97.56%
(FY 2019)
- Profit 42.09%
(FY 2019)
- Ebitda -4.79%
(FY 2019)
- Net Worth 8.50%
(FY 2019)
- Total Assets 67.42%
(FY 2019)
About Orig Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹6.57 M, as per Ministry of Corporate Affairs (MCA) records.
Jean Kamal and Lakshmi Jean serve as directors at the Company.
- CIN/LLPIN
U24232KA2015PTC078623
- Company No.
078623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2015
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Orig Pharmaceuticals Private Limited offer?
Orig Pharmaceuticals Private Limited offers a wide range of products and services, including Oxygen Mask, Nasal Cannula, Oxygen Mask, Flowmeter & Humidifier Bottle, Patient Monitoring System, Pressure Monitoring Line, Catheter, Catheter Mounts, Surgical & ICU Equipments, Ventilator Parts & Consumables, Medical Supplies.
Who are the key members and board of directors at Orig Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jean Kamal  | Director | 30-Jan-2015 | Current |
| Lakshmi Jean | Director | 30-Jan-2015 | Current |
Financial Performance of Orig Pharmaceuticals.
Orig Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 97.56% increase. The company also saw a substantial improvement in profitability, with a 42.09% increase in profit. The company's net worth moved up by a moderate rise of 8.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orig Pharmaceuticals?
In 2019, Orig Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Tunga Bhadra Dam Garden Ropeway Private LimitedActive 2 years 8 months
Jean Kamal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 25 Sep 2018 | ₹1.00 Cr | Open |
State Bank Of Travancore Creation Date: 30 Jul 2015 | ₹5.00 M | Satisfied |
State Bank Of Travancore Creation Date: 24 Jul 2015 | ₹1.57 M | Satisfied |
How Many Employees Work at Orig Pharmaceuticals?
Unlock and access historical data on people associated with Orig Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orig Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orig Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
